INO logo

Inovio Pharmaceuticals (INO) Revenue

Annual Revenue

$832.00 K
-$9.43 M-91.89%

31 December 2023

INO Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

N/A

30 September 2024

INO Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

N/A

30 September 2024

INO TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

INO Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-91.9%--
3 y3 years-88.8%--
5 y5 years-97.3%--

INO Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-91.9%at low
5 y5 years-97.3%at low
alltimeall time-98.0%+933.5%

Inovio Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
June 2024
-
$100.80 K(-1.9%)
$591.90 K(-28.9%)
Dec 2023
$832.00 K(-91.9%)
$102.70 K(-73.6%)
$832.00 K(-2.6%)
Sept 2023
-
$388.40 K(+71.9%)
$854.00 K(-91.1%)
June 2023
-
$226.00 K(+96.7%)
$9.62 M(-5.5%)
Mar 2023
-
$114.90 K(-7.9%)
$10.18 M(-0.8%)
Dec 2022
$10.26 M(+478.2%)
$124.70 K(-98.6%)
$10.26 M(-6.5%)
Sept 2022
-
$9.15 M(+1067.0%)
$10.98 M(+419.2%)
June 2022
-
$784.40 K(+294.0%)
$2.11 M(+31.9%)
Mar 2022
-
$199.10 K(-76.3%)
$1.60 M(-9.7%)
Dec 2021
$1.77 M(-76.1%)
$839.10 K(+187.7%)
$1.77 M(-72.8%)
Sept 2021
-
$291.70 K(+6.9%)
$6.52 M(+0.9%)
June 2021
-
$272.80 K(-26.5%)
$6.46 M(+0.1%)
Mar 2021
-
$371.10 K(-93.4%)
$6.46 M(-12.9%)
Dec 2020
$7.41 M(+80.2%)
$5.58 M(+2262.7%)
$7.41 M(+251.2%)
Sept 2020
-
$236.20 K(-11.6%)
$2.11 M(-23.0%)
June 2020
-
$267.20 K(-79.9%)
$2.74 M(+5.0%)
Mar 2020
-
$1.33 M(+374.9%)
$2.61 M(-36.5%)
Dec 2019
$4.11 M(-86.5%)
$279.50 K(-67.8%)
$4.11 M(-35.1%)
Sept 2019
-
$866.90 K(+538.8%)
$6.34 M(-15.2%)
June 2019
-
$135.70 K(-95.2%)
$7.47 M(-76.5%)
Mar 2019
-
$2.83 M(+13.1%)
$31.78 M(+4.3%)
Dec 2018
$30.48 M(-27.8%)
$2.50 M(+25.1%)
$30.48 M(-17.1%)
Sept 2018
-
$2.00 M(-91.8%)
$36.77 M(-1.7%)
June 2018
-
$24.45 M(+1498.4%)
$37.41 M(+12.1%)
Mar 2018
-
$1.53 M(-82.6%)
$33.37 M(-21.0%)
Dec 2017
$42.22 M(+19.4%)
$8.79 M(+232.3%)
$42.22 M(+0.7%)
Sept 2017
-
$2.64 M(-87.0%)
$41.95 M(-19.1%)
June 2017
-
$20.41 M(+96.7%)
$51.84 M(+37.8%)
Mar 2017
-
$10.38 M(+21.9%)
$37.63 M(+6.4%)
Dec 2016
$35.37 M(-12.8%)
$8.51 M(-32.1%)
$35.37 M(+7.9%)
Sept 2016
-
$12.54 M(+102.1%)
$32.79 M(-26.2%)
June 2016
-
$6.20 M(-23.5%)
$44.43 M(+2.1%)
Mar 2016
-
$8.11 M(+36.6%)
$43.52 M(+7.3%)
Dec 2015
$40.57 M(+288.0%)
$5.94 M(-75.5%)
$40.57 M(+9.4%)
Sept 2015
-
$24.18 M(+357.4%)
$37.09 M(+151.5%)
June 2015
-
$5.29 M(+2.3%)
$14.75 M(+11.2%)
Mar 2015
-
$5.17 M(+110.3%)
$13.27 M(+26.9%)
Dec 2014
$10.46 M(-22.4%)
$2.46 M(+33.5%)
$10.46 M(+7.4%)
Sept 2014
-
$1.84 M(-51.6%)
$9.74 M(-44.0%)
June 2014
-
$3.80 M(+61.3%)
$17.39 M(+21.0%)
Mar 2014
-
$2.36 M(+35.5%)
$14.37 M(+6.7%)
Dec 2013
$13.47 M(+227.0%)
$1.74 M(-81.7%)
$13.47 M(+4.7%)
Sept 2013
-
$9.49 M(+1107.6%)
$12.86 M(+204.1%)
June 2013
-
$785.60 K(-46.0%)
$4.23 M(+9.0%)
Mar 2013
-
$1.46 M(+28.2%)
$3.88 M(-5.8%)
Dec 2012
$4.12 M(-58.0%)
$1.13 M(+32.8%)
$4.12 M(-10.8%)
Sept 2012
-
$854.70 K(+96.0%)
$4.62 M(-27.9%)
June 2012
-
$436.10 K(-74.2%)
$6.40 M(-23.7%)
Mar 2012
-
$1.69 M(+3.7%)
$8.38 M(-14.4%)
Dec 2011
$9.80 M
$1.63 M(-38.1%)
$9.80 M(-6.9%)
Sept 2011
-
$2.64 M(+9.0%)
$10.52 M(+14.9%)
DateAnnualQuarterlyTTM
June 2011
-
$2.42 M(-22.1%)
$9.16 M(+16.3%)
Mar 2011
-
$3.11 M(+31.6%)
$7.88 M(+28.2%)
Dec 2010
$6.14 M(-32.6%)
$2.36 M(+84.9%)
$6.14 M(-4.0%)
Sept 2010
-
$1.28 M(+12.5%)
$6.40 M(-27.0%)
June 2010
-
$1.13 M(-17.4%)
$8.77 M(-13.4%)
Mar 2010
-
$1.37 M(-47.4%)
$10.12 M(+11.0%)
Dec 2009
$9.12 M(+334.8%)
$2.61 M(-28.4%)
$9.12 M(+33.4%)
Sept 2009
-
$3.65 M(+46.4%)
$6.83 M(+87.6%)
June 2009
-
$2.49 M(+574.3%)
$3.64 M(+100.8%)
Mar 2009
-
$369.50 K(+13.1%)
$1.81 M(-13.5%)
Dec 2008
$2.10 M(-56.4%)
$326.80 K(-28.1%)
$2.10 M(-58.8%)
Sept 2008
-
$454.70 K(-31.4%)
$5.09 M(-0.6%)
June 2008
-
$663.00 K(+1.5%)
$5.12 M(+3.4%)
Mar 2008
-
$653.00 K(-80.3%)
$4.96 M(+3.1%)
Dec 2007
$4.81 M(+38.6%)
$3.32 M(+582.8%)
$4.81 M(+59.3%)
Sept 2007
-
$486.50 K(-1.8%)
$3.02 M(-2.9%)
June 2007
-
$495.60 K(-1.6%)
$3.11 M(-5.1%)
Mar 2007
-
$503.90 K(-67.1%)
$3.27 M(-5.6%)
Dec 2006
$3.47 M(-36.6%)
$1.53 M(+166.0%)
$3.47 M(+25.4%)
Sept 2006
-
$575.80 K(-13.1%)
$2.77 M(-5.1%)
June 2006
-
$662.70 K(-5.1%)
$2.91 M(-44.0%)
Mar 2006
-
$698.00 K(-15.8%)
$5.20 M(-4.8%)
Dec 2005
$5.47 M(+368.5%)
$829.20 K(+14.5%)
$5.47 M(+5.5%)
Sept 2005
-
$724.50 K(-75.5%)
$5.18 M(+5.5%)
June 2005
-
$2.95 M(+206.9%)
$4.91 M(+138.5%)
Mar 2005
-
$961.90 K(+77.2%)
$2.06 M(+76.5%)
Dec 2004
$1.17 M(+1349.8%)
$542.70 K(+19.2%)
$1.17 M(+76.2%)
Sept 2004
-
$455.20 K(+356.1%)
$662.50 K(+188.5%)
June 2004
-
$99.80 K(+43.8%)
$229.60 K(+65.4%)
Mar 2004
-
$69.40 K(+82.2%)
$138.80 K(+72.4%)
Dec 2003
$80.50 K(-57.5%)
$38.10 K(+70.9%)
$80.50 K(-32.1%)
Sept 2003
-
$22.30 K(+147.8%)
$118.60 K(-27.8%)
June 2003
-
$9000.00(-18.9%)
$164.20 K(-16.3%)
Mar 2003
-
$11.10 K(-85.4%)
$196.20 K(+3.5%)
Dec 2002
$189.50 K(+71.3%)
$76.20 K(+12.2%)
$189.60 K(+67.2%)
Sept 2002
-
$67.90 K(+65.6%)
$113.40 K(-91.6%)
June 2002
-
$41.00 K(+811.1%)
$1.35 M(-37.2%)
Mar 2002
-
$4500.00(-99.7%)
$2.14 M(-44.1%)
Dec 2001
$110.60 K(-97.4%)
-
-
Sept 2001
-
$1.30 M(+55.4%)
$3.84 M(-6.9%)
June 2001
-
$837.70 K(+65.4%)
$4.12 M(-10.3%)
Mar 2001
-
$506.40 K(-57.5%)
$4.60 M(-17.4%)
Mar 2001
$4.29 M(-15.5%)
-
-
Dec 2000
-
$1.19 M(-25.0%)
$5.57 M(-0.2%)
Sept 2000
-
$1.59 M(+21.0%)
$5.58 M(+1.6%)
June 2000
-
$1.31 M(-11.3%)
$5.49 M(+8.1%)
Mar 2000
$5.08 M(-39.0%)
$1.48 M(+23.1%)
$5.08 M(-44.3%)
Dec 1999
-
$1.20 M(-20.0%)
$9.12 M(+3.4%)
Sept 1999
-
$1.50 M(+66.7%)
$8.82 M(+20.5%)
June 1999
-
$900.00 K(-83.7%)
$7.32 M(+14.0%)
Mar 1999
$8.32 M
$5.52 M(+513.5%)
$6.42 M(+613.5%)
Dec 1998
-
$900.00 K
$900.00 K

FAQ

  • What is Inovio Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for Inovio Pharmaceuticals?
  • What is Inovio Pharmaceuticals annual revenue year-on-year change?
  • What is the all time high quarterly revenue for Inovio Pharmaceuticals?
  • What is the all time high TTM revenue for Inovio Pharmaceuticals?

What is Inovio Pharmaceuticals annual revenue?

The current annual revenue of INO is $832.00 K

What is the all time high annual revenue for Inovio Pharmaceuticals?

Inovio Pharmaceuticals all-time high annual revenue is $42.22 M

What is Inovio Pharmaceuticals annual revenue year-on-year change?

Over the past year, INO annual revenue has changed by -$9.43 M (-91.89%)

What is the all time high quarterly revenue for Inovio Pharmaceuticals?

Inovio Pharmaceuticals all-time high quarterly revenue is $24.45 M

What is the all time high TTM revenue for Inovio Pharmaceuticals?

Inovio Pharmaceuticals all-time high TTM revenue is $51.84 M